Eloxx Pharmaceuticals (ELOX) Reports Q1 Loss of $0.31/Share
Tweet
Share
E-mailGet Alerts ELOX Hot Sheet
Join SI Premium – FREE
Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q1 EPS of ($0.31), versus ($0.73) reported last year.
For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- William Blair Downgrades Endava PLC (ADR) (DAVA) to Underperform
- Leerink Starts Eloxx Pharma (ELOX) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
